These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 6234122

  • 1. [Use of buflomedil in the treatment of obliterative arteriopathies of the lower extremities. Clinical and functional study].
    Cospite M, Ferrara F, Milio G, Meli F.
    Clin Ter; 1984 Apr 30; 109(2):127-35. PubMed ID: 6234122
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies].
    Tallarida G, Baldoni F, Peruzzi G, Raimondi G, Grimaldi I, Visigalli G, Gristina S, Massaro M, De Martinis L, Sangiorgi M.
    Cardiologia; 1983 Aug 30; 28(8):651-60. PubMed ID: 6687209
    [No Abstract] [Full Text] [Related]

  • 5. [Effects of buflomedil on peripheral arteriopathies. An open clinical study].
    Longo FN, Potortì F, Urbano O, Perroni GB.
    Minerva Cardioangiol; 1988 May 30; 36(5):249-52. PubMed ID: 3059229
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs].
    Lucisano V, Margheriti R, Matone P, Morrieri C, Rugolo A, Corsi V.
    Clin Ter; 1986 Jun 30; 117(6):499-509. PubMed ID: 3527536
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Multicenter study on the therapeutic activity of buflomedil chlorhydrate in obliterative arteriopathies of the legs].
    Allegra C, Andreozzi GM, Avellone G, Cospite M, Del Guercio R, Lepore R, Nuzzaci G, Pinto A, Romeo S.
    Clin Ter; 1986 Oct 15; 119(1):25-33. PubMed ID: 3539466
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Internal conservative treatment of obliterative arteriopathies of the lower limbs].
    Toth L.
    Med Pregl; 1975 Oct 15; 28(3-4):181-3. PubMed ID: 1177851
    [No Abstract] [Full Text] [Related]

  • 14. [Novocain-histamine iontophoresis in the treatment of obliterative artheriosclerosis of the lower limbs].
    Darewicz J, Obrzut A.
    Pol Tyg Lek; 1967 Oct 15; 22(40):1524-6. PubMed ID: 6062536
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of Sadamin on some blood clotting parameters and fibrinolysis in patients with obliterative arteriosclerosis of lower limb arteries].
    Kiersnowska B, Bielawiec M, Lukjan H, Korfel B, Rogowski F, Dowzyk W.
    Pol Tyg Lek; 1973 Mar 12; 28(11):400-3. PubMed ID: 4694796
    [No Abstract] [Full Text] [Related]

  • 16. [Human chorionic gonadotropin in the treatment of chronic peripheral obliterative arteriosclerotic arteriopathies of the lower limbs].
    Bagliani A, Moia R.
    Minerva Med; 1978 Apr 21; 69(19):1287-93. PubMed ID: 662155
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Ozone therapy, a new method of treating chronic obliterating arteriopathies].
    Ionescu G, Pitea P, Blaj A.
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985 Apr 21; 34(3):207-13. PubMed ID: 2931752
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.